Orofacial movements in phospholipase C-related catalytically inactive protein-1/2 double knockout mice: Effect of the GABAergic agent diazepam and the D1 dopamine receptor agonist SKF 83959

Synapse

Volumn 64, Issue 9, 2010, Pages 714-720

  Tomiyama, Katsunori ^a   Song, Liqiu ^a   Kobayashi, Masayuki ^a   Kinsella, Anthony ^b   Kanematsu, Takashi ^c   Hirata, Masato ^d   Koshikawa, Noriaki ^a   Waddington, John L ^b  

^a NIHON UNIVERSITY   (Japan)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c HIROSHIMA UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

D1 receptors; Diazepam; GABAA receptors; Phenotype; PRIP 1 2 knockout; SKF 83959

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; DIAZEPAM; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; PHOSPHOLIPASE C; PHOSPHOLIPASE C RELATED CATALYTICALLY INACTIVE PROTEIN; PHOSPHOLIPASE C RELATED CATALYTICALLY INACTIVE PROTEIN 1; PHOSPHOLIPASE C RELATED CATALYTICALLY INACTIVE PROTEIN 2; PROTEIN; UNCLASSIFIED DRUG; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; CARRIER PROTEIN; DOPAMINE RECEPTOR STIMULATING AGENT; PLCL2 PROTEIN, MOUSE; PRIP-1 PHOSPHOLIPASE C-RELATED PROTEIN, MOUSE; SIGNAL PEPTIDE; SK&F 83959;

ANIMAL EXPERIMENT; ARTICLE; CELL SURFACE; DRUG EFFECT; DRUG MECHANISM; FEMALE; GABAERGIC SYSTEM; GENE EXPRESSION; HEAD MOVEMENT; INCISOR; JAW MOVEMENT; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BINDING; TONGUE; VIBRISSA; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECTS; FACE; GENETICS; MOTOR ACTIVITY; MOUTH; MOVEMENT (PHYSIOLOGY); PHYSIOLOGY;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; BEHAVIOR, ANIMAL; CARRIER PROTEINS; DIAZEPAM; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FACE; FEMALE; GABA MODULATORS; HEAD MOVEMENTS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; MOUTH; MOVEMENT; RECEPTORS, DOPAMINE D1; VIBRISSAE;

EID: 77956478580     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20798     Document Type: Article

References (32)

1. 1-like receptors. Eur J Pharmacol 473:47-54.
2. 1 receptor facilitation of depolarization-induced release of gamma-amino-butyric acid in rat striatum is mediated by the cAMP/PKA pathway and involves P/Q-type calcium channels. Synapse 61:310-319.
3. Berthoud H-R. 2003. Neurochemical control and reconfiguration of the medullary network controlling different oromotor behaviors. Am J Physiol Regul Integr Comp Physiol 285:R19-R20.
4. A receptor function. J Neurochem 100:279-294.
5. Clark GT, Ram S. 2007. Four oral motor disorders: Bruxism, dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions. Dent Clin North Am 51:225-243. (Pubitemid 44917951)
6. 1B receptors in the ventrolateral striatum differentially modulate apomorphine-induced jaw movements in rats. J Oral Sci 50:387-395.
7. A receptor function to modulate hippocampal neural progenitor cell proliferation. J Neurochem 107:964-975.
8. 1-mediated dopamine turnover as measured by dual probe microdialysis in rats. Neuroscience 100:507-514.
9. 1 receptor subtype. Neurochem Res 32:229-240.
10. A receptor function. EMBO J 21:1004-1011.
11. A receptor phosphorylation and membrane trafficking by phospholipase C-related inactive protein/protein phosphatase 1 and 2A signaling complex underlying brain-derived neurotrophic factor-dependent regulation of GABAergic inhibition. J Biol Chem 281:22180-22189.
12. A receptor-associated protein) and PRIP (phospholipase C-related, but catalytically inactive protein). J Pharmacol Sci 104:285-292.
13. Luo P, Zhang J, Yang R, Pendlebury W. 2006. Neuronal circuitry and synaptic organization of trigeminal proprioceptive afferents mediating tongue movement and jaw-tongue coordination via hypoglossal premotor neurons. Eur J Neurosci 23:3269-3283.
14. 1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): Studies of tremulous jaw movements in rats. Psychopharmacology 143:72-81.
15. A receptors to the cell surface. J Neurosci 27:1692-1701.
16. 2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements. Eur J Pharmacol 428:81-86.
17. A receptors: Subtypes provide diversity of function and pharmacology. Neuropharmacology 56:141-148.
18. Peixoto MF, Araujo NP, Silva RH, Castro JP, Fukushiro DF, Faria RR, Zanier-Gomes PH, Medrano WA, Frussa-Filho R, Abílio VC. 2005. Effects of gabaergic drugs on reserpine-induced oral dyskinesia. Behav Brain Res 160:51-59.
19. A receptor subtype functions: the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 90:37-42.
20. Sokal RR, Rohlf FJ. 1995. Biometry. New York, NY: WH Freeman & Co.
21. 2-like receptor regulation. Eur J Pharmacol 418:47-54.
22. 1A receptor 'knockout' mice. Neuropharmacology 42:644-652.
23. 3 receptor 'knockout'. Synapse 51:71-81.
24. Towers SK, Hestrin S. 2008. D1-like dopamine receptor activation modulates GABAergic inhibition but not electrical coupling between neocortical fast-spiking interneurons. J Neurosci 28:2633-2641. (Pubitemid 351348189)
25. Trosch RM. 2004. Neuroleptic-induced movement disorders: Deconstructing extrapyramidal symptoms. J Am Geriatr Soc 52:S266-271.
26. 2 receptor occupancy? Neurosci Biobehav Rev 26:361-380.
27. 3 binding protein type 2 - Comparison with PRIP-1. Life Sci 72:443-453.
28. Waddington JL. 1990. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: Phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology (Berl) 101:431-447.
29. 2-like' receptors. Prog Neuro-Psychopharmacol and Biol Psychiatry 19:811-831.
30. Waddington JL, O'Tuathaigh C, O'Sullivan G, Tomiyama K, Koshikawa N, Croke DT. 2005. Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: Insights and challenges from 10 years at the psychopharmacology-molecular biology interface. Psychopharmacology 181:611-638.
31. Whitty PF, Owoeye O, Waddington JL. 2009. Neurological signs and involuntary movements in schizophrenia: Intrinsic to and informative on systems pathobiology. Schizophr Bull 35:415-424.
32. Yeghiayan SK, Kelley AE. 1995. Serotonergic stimulation of the ventrolateral striatum induces orofacial stereotypy. Pharmacol Biochem Behav 52:493-501.